Infectious Disease
Overview
Globally, human lifespans have been increasing in large part due to advances in treating and eliminating infectious diseases. Yet, the threat from emerging, reemerging and entrenched infectious diseases remains a challenge for society. Traditional methodology has had success in the past, but with an ever-globalizing world, the need for fast, accurate and comprehensive research is paramount. Partnering with international collaborators is enabling JCVI to be the catalyst for better understanding and potential new treatments against the scourge of infectious disease.
Team
News
Statement on cuts to National Institutes of Health funding
Disruptions or reductions in funding may irreparably harm biomedical research efforts at J. Craig Venter Institute and in the broader research ecosystem
J. Craig Venter Institute scientists awarded five-year, $5.7M grant from NIH to develop phage treatment
Phage research accelerates with the rise of antibiotic resistance to address increasingly prevalent and difficult to treat bacterial infections
PolyBio Research Foundation Consortium & colleagues publishes Nature position paper on SARS-CoV-2 reservoir in Long COVID/PASC
Family resemblance: How T cells could fight many coronaviruses at once
LJI researchers work to head off future pandemics by uncovering key similarities between SARS-CoV-2 and common cold coronaviruses
Scientists aim to develop vaccine against all deadly coronaviruses
$8 million NIH grant supports effort to avert next pandemic
What are the Drivers of Chronic Infectious Disease?
A $1 million grant from the Steven & Alexandra Cohen Foundation will launch a UC San Diego-led national effort to more deeply study tissue samples from patients with conditions ranging from long COVID-19 and relapsed Lyme disease to chronic fatigue syndrome
The Tissue Analysis Pipeline will be directed by scientists at UC San Diego and the J. Craig Venter Institute
Top scientists join forces to study leading theory behind long COVID
Several JCVI scientists will be contributing to the newly launched Long Covid Research Initiative — a collaboration of researchers, clinicians, and patients working to rapidly study and treat long Covid.
Omicron and Beta variants evade antibodies elicited by vaccines and previous infections, but boosters help
Pregnancy also contributes to a reduced COVID-19 antibody response
SARS-CoV-2 Mutation Tracking
J. Craig Venter Institute Scientists to Investigate Role of Opioid Abuse in HIV and HIV-Associated Neurocognitive Disorders Pathogenesis through $4.7M NIDA Grant
Study aims to identify candidate molecules to regulate HIV infection in the central nervous system in patients abusing opioids
Scientists rush to determine if mutant strain of coronavirus will deepen pandemic
U.S. researchers have been slow to perform the genetic sequencing that will help clarify the situation
Unique Antibody Pattern Discovered in COVID-19 ICU Patients May Be Key to Predicting Severe Outcomes
COVID-19 Further Complicating Flu Season
Coronavirus Pandemic: Putting Comprehensive Genomic Data in the Hands of Frontline Researchers Worldwide is Paramount
Venter Institute Researchers Tackle the Growing Concern of Antibiotic Resistant Bacterial Infections with Genomic, Phage Approaches
J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease
Team targeted specific toxin-producing strains of the bacterium, Enterococcus faecalis, which is shown to be responsible for most liver damage
Combining Antibiotics, Researchers Deliver One-Two Punch against Ubiquitous Bacterium
CWRU/Cleveland VA findings in mouse models could make inroads against superbugs
New Sequencing Technologies Enable Better and Faster Understanding of the Human Microbiome
Genetically modified bacteria-killing viruses used on patient for first time
Oral bacteria 'battle royale' helps explain how a pathogen causes hospital infections
When Starved, Dangerous Oral Bacteria Hang On
Fighting Back Against Flu
Every Day is World Food Day at JCVI
Mold Is Everywhere and Impacts You
Past encounters with the flu shape vaccine response
Immune history influences vaccine effectiveness, interacting with other potential problems arising from the manufacturing process